Risk associated with a systematic search of extended-spectrum ß-lactamase-producing Enterobacteriaceae.
Am J Infect Control
; 41(3): 259-60, 2013 Mar.
Article
en En
| MEDLINE
| ID: mdl-23062579
ABSTRACT
We evaluated 74 children with previous fecal extended-spectrum ß-lactamase (ESBL)-producing Enterobacteriaceae colonization who were hospitalized and receiving a course of antibiotic therapy for suspected infection. Sixty-four patients (86.5%) received a carbapenem agent. Only 3 patients were infected with an ESBL-producing Enterobacteriaceae. Sixty-one (95%) initial antibiotic courses were considered excessive and required deescalation; however, deescalation was accomplished in only 38 patients (62%). This suggests the need for an ESBL control program to decrease carbapenem use and thereby limit carbapenem resistance in gram-negative bacilli.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Beta-Lactamasas
/
Carbapenémicos
/
Enterobacteriaceae
/
Infecciones por Enterobacteriaceae
/
Antibacterianos
Tipo de estudio:
Etiology_studies
/
Risk_factors_studies
Límite:
Child
/
Humans
Idioma:
En
Revista:
Am J Infect Control
Año:
2013
Tipo del documento:
Article
País de afiliación:
Francia